MedTrace Logo

Renal Denervation in Patients With Resistant Hypertension and Obstructive Sleep Apnea

NCT01366625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-01-26

No results posted yet for this study

Summary

The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of resistant hypertension coexisting with obstructive sleep apnea.

Conditions

Interventions

DEVICE

Renal denervation with a catheter-based procedure (Symplicity® Catheter System)

Disruption of the renal nerves with a catheter-based procedure.

Sponsors & Collaborators

  • National Institute of Cardiology, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Aleksander Prejbisz, M.D., Ph.D. · Institute of Cardiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2016-02-08
Completion
2016-11-28

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01366625 on ClinicalTrials.gov